NEWS
View news from our Featured Companies.
Aytu BioPharma Announces Launch of Public Offering
ENGLEWOOD, CO / August 8, 2022 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced the launch of an underwritten public offering of shares of its common...
Scientific Industries’ Scientific Bioprocessing (SBI) Introduces DOTS, The New Sensor Platform to Digitally Simplify Bioprocessing
BOHEMIA, NY and PITTSBURGH, PA / August 8, 2022 / Scientific Industries, Inc. (OTCQB:SCND), a life science tool provider, and a developer of digitally simplified products, announced today its subsidiary Scientific Bioprocessing (SBI) announces the launch of DOTS, a...
INVO Bioscience to Report Second Quarter 2022 Financial Results on Monday, August 15, 2022
Financial results to be released after market close; Conference call to be conducted at 4:30 pm ET SARASOTA, Fla., Aug. 4, 2022 -- INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide...
SenesTech to Report Second Quarter 2022 Financial Results on Thursday, August 11, 2022
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, Aug. 4, 2022 -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its second quarter 2022, ended June 30, 2022, after the market close on...
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2022
Conference Call Scheduled for Friday, August 12, 2022 at 9:00 AM ETPORTLAND, Maine, Aug. 04, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and...
InfuSystem Reports Second Quarter 2022 Financial Results
Net Revenues increased 9% to $27 million; ITS revenues increased 6% and DME revenues increased 15% ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU), ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating...
PolyPid Announces Exclusive Licensing Agreement with ADVANZ PHARMA for the Commercialization of D-PLEX in Europe
PolyPid to potentially receive over $110 million in upfront and milestone payments as well as royalties on net sales ADVANZ PHARMA to receive exclusive rights to commercialize D-PLEX100 for the prevention of surgical site infections in abdominal and cardiac surgeries...
LiqTech International to Discuss Second Quarter 2022 Results on Thursday, August 11, 2022
Management to Host Conference Call on Thursday, August 11, 2022, at 9:00 a.m. ET BALLERUP, Denmark, Aug. 2, 2022 -- LiqTech International, Inc. (NASDAQ: LIQT), a clean technology company that manufactures and markets highly specialized filtration products and systems,...
ChromaDex to Report Second Quarter 2022 Financial Results on Wednesday, August 10, 2022
LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Wed. August 10, 2022 at 4:30 p.m. ET to discuss its financial results for the second quarter, which ended June 30, 2022. The financial results will be reported in a press...
Elevate Bait System™ with ContraPest® is Now Available in California
PHOENIX, Aug. 1, 2022 -- SenesTech, Inc., (SNES), the rodent fertility control experts, announced that its new Elevate Bait System™ with ContraPest®, the only EPA registered birth control for both male and female rats, is available for sale in all fifty...
InfuSystem to Report Second Quarter 2022 Financial Results on August 4, 2022
Investor Conference Call to be held 9:00 a.m. Eastern Time ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical...
IRADIMED CORPORATION Announces Second Quarter 2022 Financial Results
Reports second quarter 2022 revenue of $12.7 million, GAAP diluted EPS of $0.26 and non-GAAP diluted EPS of $0.26Announces third quarter 2022 financial guidance WINTER SPRINGS, Fla., July 29, 2022 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD), announced today...
Mogo Schedules Q2 2022 Earnings Conference Call
VANCOUVER, British Columbia - Mogo Inc. (TSX:MOGO) (NASDAQ:MOGO) ("Mogo" or the "Company"), a digital payments and financial technology company, today announced it will hold a conference call and webcast to discuss its Q2 2022 financial results on Thursday, August 11,...
LiqTech Announces Appointment of Fei Chen as President and CEO
BALLERUP, Denmark, July 29, 2022 -- LiqTech International, Inc. (NASDAQ: LIQT), a clean technology company that manufactures and markets highly specialized filtration products and systems, today announced the appointment of Fei Chen as President and Chief Executive...
UPDATE – IRADIMED CORPORATION to Hold 2022 Second Quarter Financial Results Conference Call on July 29th
WINTER SPRINGS, Fla., July 28, 2022 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 second quarter financial results before the market opens on Friday, July 29th. IRADIMED management will host a conference call the same...
Kiora Pharmaceuticals Issued US Patent Covering KIO-201 Technology in Combination with Antibiotics
Salt Lake City, Utah--(July 28, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") has been granted a U.S. patent covering hydrogel-based sustained release platforms, inclusive of KIO-201, which enable controlled release of antibiotics for...
ImmuCell Receives Technical Section Incomplete Letter from FDA Pertaining to Re-Tain®
PORTLAND, Maine, July 27, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
Reviva Pharmaceuticals Provides Update on Clinical Development Pipeline
Enrollment remains on pace for Reviva's Phase 3 clinical trial for the treatment of schizophrenia at 15 sites across the US with enrollment set to begin at sites in Europe and India in Q3 2022 More than 20% of the approximately 400 patients planned for Phase 3 trial...
PolyPid to Report Second Quarter 2022 Financial Results and Operational Highlights on August 10, 2022
PETACH TIKVA, Israel, July 27, 2022 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its second quarter 2022 financial results and operational...
Kiora Pharmaceuticals Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
Salt Lake City, Utah--(July 26, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") today announced the closing of an underwritten public offering for gross proceeds of approximately $6.0 million, which includes full exercise of the...
Modular Medical Appoints Kevin Schmid as Chief Operating Officer
Schmid brings 40 years of experience in medical devices for drug delivery and diabetes management and a background in high-volume manufacturingSAN DIEGO, CA / July 26, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical")(NASDAQ:MODD) today announced that...
Aytu BioPharma to Participate in the Canaccord Genuity 42nd Annual Growth Conference
ENGLEWOOD, CO / July 26, 2022 / Aytu BioPharma, Inc. (the "Company") (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced that Chief Executive Officer Josh Disbrow and Chief Financial Officer Mark Oki...
PolyPid Announces Presentation of Phase 2 D-PLEX Clinical Data at the Midwest Surgical Association 2022 Annual Meeting
Efficacy Data of D-PLEX100 in the Prevention of Post-Abdominal Surgery Incisional Infection in High-Risk Patients will be Presented During a Podium Presentation PETACH TIKVA, Israel, July 25, 2022 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a...
IRADIMED CORPORATION to Hold 2022 Second Quarter Financial Results Conference Call on July 29th
WINTER SPRINGS, Fla., July 22, 2022 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 second quarter financial results before the market opens on Friday, July 29th. IRADIMED management will host a conference call the same...
Kiora Pharmaceuticals Announces Pricing of $5.2 Million Underwritten Public Offering
Salt Lake City, Utah--(July 22, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") today announced the pricing of an underwritten public offering for gross proceeds of approximately $5.2 million prior to deducting underwriting discounts and...